Prophylactic anticoagulants for people hospitalised with COVID‐19

BACKGROUND: Coronavirus disease 2019 (COVID‐19) is a serious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). The primary manifestation is respiratory insufficiency that can also be related to diffuse pulmonary microthrombosis in people with COVID‐19. This disease also...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cochrane Database Syst Rev
Autors principals: Flumignan, Ronald LG, Tinôco, Jéssica Dantas de Sá, Pascoal, Patricia IF, Areias, Libnah L, Cossi, Marcelly S, Fernandes, Maria ICD, Costa, Isabelle KF, Souza, Larissa, Matar, Charbel F, Tendal, Britta, Trevisani, Virginia FM, Atallah, Álvaro N, Nakano, Luis CU
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Ltd 2020
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8166900/
https://ncbi.nlm.nih.gov/pubmed/33502773
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD013739
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars